Smart Money Is Betting Big In LLY Options
Smart Money Is Betting Big In LLY Options
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 21 unusual trades.
金融巨頭對禮來採取了明顯的看跌舉動。我們對禮來（紐約證券交易所代碼：LLY）期權歷史的分析顯示了21筆不尋常的交易。
Delving into the details, we found 28% of traders were bullish, while 52% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $168,350, and 17 were calls, valued at $1,103,918.
深入研究細節，我們發現28％的交易者看漲，而52％的交易者表現出看跌傾向。在我們發現的所有交易中，有4筆是看跌期權，價值爲168,350美元，17筆是看漲期權，價值1,103,918美元。
Projected Price Targets
預計價格目標
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $400.0 to $1080.0 for Eli Lilly over the recent three months.
根據交易活動，看來重要投資者的目標是在最近三個月中將禮來的價格區間從400.0美元擴大到1080.0美元。
Insights into Volume & Open Interest
對交易量和未平倉合約的見解
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平倉合約是一種對股票進行盡職調查的有見地的方法。
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
這些數據可以幫助您跟蹤禮來公司期權在給定行使價下的流動性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $400.0 to $1080.0 in the last 30 days.
下面，我們可以觀察到過去30天內禮來公司在行使價範圍內所有鯨魚活動的看漲和看跌期權交易量和未平倉合約的分別變化。
Eli Lilly Option Activity Analysis: Last 30 Days
禮來期權活動分析：過去 30 天
Significant Options Trades Detected:
檢測到的重要期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BEARISH | 12/19/25 | $143.95 | $137.65 | $139.35 | $940.00 | $249.1K | 220 | 17 |
| LLY | CALL | TRADE | NEUTRAL | 01/16/26 | $410.4 | $399.8 | $405.8 | $550.00 | $202.9K | 57 | 0 |
| LLY | CALL | SWEEP | BULLISH | 09/13/24 | $5.0 | $4.65 | $5.0 | $930.00 | $92.5K | 906 | 252 |
| LLY | CALL | TRADE | BULLISH | 11/15/24 | $61.0 | $59.05 | $61.0 | $910.00 | $54.9K | 230 | 15 |
| LLY | PUT | TRADE | NEUTRAL | 09/13/24 | $58.4 | $52.0 | $54.85 | $960.00 | $54.8K | 47 | 0 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 莉莉 | 打電話 | 掃 | 粗魯的 | 12/19/25 | 143.95 美元 | 137.65 美元 | 139.35 美元 | 940.00 美元 | 249.1 萬美元 | 220 | 17 |
| 莉莉 | 打電話 | 貿易 | 中立 | 01/16/26 | 410.4 美元 | 399.8 美元 | 405.8 美元 | 550.00 美元 | 202.9 萬美元 | 57 | 0 |
| 莉莉 | 打電話 | 掃 | 看漲 | 09/13/24 | 5.0 美元 | 4.65 美元 | 5.0 美元 | 930.00 美元 | 92.5 萬美元 | 906 | 252 |
| 莉莉 | 打電話 | 貿易 | 看漲 | 11/15/24 | 61.0 美元 | 59.05 美元 | 61.0 美元 | 910.00 美元 | 54.9 萬美元 | 230 | 15 |
| 莉莉 | 放 | 貿易 | 中立 | 09/13/24 | 58.4 美元 | 52.0 美元 | 54.85 美元 | 960.00 美元 | 54.8 萬美元 | 47 | 0 |
About Eli Lilly
關於 Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來公司的關鍵產品包括用於癌症的Verzenio；用於心臟代謝的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於禮來公司最近的期權歷史，現在應該專注於公司本身。我們的目標是探索其目前的表現。
Current Position of Eli Lilly
禮來公司目前的職位
- With a trading volume of 330,623, the price of LLY is up by 0.36%, reaching $906.0.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 52 days from now.
- LLY的交易量爲330,623美元，價格上漲了0.36％，達到906.0美元。
- 當前的RSI值表明，該股目前在超買和超賣之間處於中立狀態。
- 下一份收益報告定於即日起52天后發佈。
Professional Analyst Ratings for Eli Lilly
禮來公司的專業分析師評級
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1019.2.
在過去的30天中，共有5位專業分析師對該股發表了看法，將平均目標股價定爲1019.2美元。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Consistent in their evaluation, an analyst from Guggenheim keeps a Buy rating on Eli Lilly with a target price of $1030.
- An analyst from Berenberg persists with their Buy rating on Eli Lilly, maintaining a target price of $1050.
- In a positive move, an analyst from Deutsche Bank has upgraded their rating to Buy and adjusted the price target to $1025.
- In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $1106.
- 坎託·菲茨傑拉德的一位分析師將其評級下調至增持，新的目標股價爲885美元，這反映了人們的擔憂。
- 古根海姆的一位分析師在評估中保持了對禮來公司的買入評級，目標價爲1030美元。
- 貝倫貝格的一位分析師堅持對禮來公司的買入評級，將目標價維持在1050美元。
- 德意志銀行的一位分析師將其評級上調爲買入，並將目標股價調整爲1025美元，這是一個積極的舉動。
- 摩根士丹利的一位分析師謹慎地將其評級下調至增持，將目標股價定爲1106美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。
